Press releases

2016-12-01 - Stallergenes Greer secures €50M revolving credit facility

2016-11-16 - Stallergenes Greer’s “Meet the Managers” event showcases progress towards regaining global leadership in its field

2016-11-14 - Stallergenes Greer announces collaboration with the Sean N. Parker Center for Allergy and Asthma research at Stanford University

2016-08-25 - Stallergenes Greer announces 2016 half-year results

2016-06-09 - Stallergenes Greer announces results of 2016 annual general meeting

2016-05-27 - Update on Stallergenes Greer manufacturing and distribution activities

2016-05-04 - Notification to shareholders of Annual General Meeting on 9 June 2016

2016-04-29 - Stallergenes Greer announces the publication of its 2015 Annual Report

2016-04-27 - Stallergenes Greer announces its 2015 full year results

2016-04-27 - Stallergenes Greer reports positive phase II Japanese cedar immunotherapy tablets results

2016-04-11 - Daniel Smith appointed global head of information technology

2016-04-05 - Stallergenes Greer announces the approval of ACTAIR® in Australia

2016-03-11 - Notifice to shareholders of adoption of financial reporting standard (“FRS”) 102 – ‘reduced disclosure framework’ for parent entity

2016-03-10 - Stallergenes Greer authorized to resume Named Patient Products manufacturing at its Antony, France plant

2016-02-22 - Stallergenes Greer announces its 2016 financial calendar

2016-02-10 - Michele Antonelli appointed President of Stallergenes SAS and Executive Vice President, Head of Europe & Rest of World

2016-02-01 - Stallergenes Greer announces resumption of manufacturing at its Antony, France plant

2016-02-01 - Tibor Nemes appointed Global Head of Technical Operations